FULCRUM THERAPEUTICS INC's ticker is FULC and the CUSIP is 359616109. A total of 113 filers reported holding FULCRUM THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.59 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $0 | – | 10 | 0.0% | 0.00% | – |
| Q2 2023 | $0 | -100.0% | 10 | -99.7% | 0.00% | – |
| Q1 2023 | $8,000 | -85.7% | 2,894 | -62.2% | 0.00% | – |
| Q4 2022 | $56,000 | +1766.7% | 7,651 | +1658.9% | 0.00% | – |
| Q3 2022 | $3,000 | +200.0% | 435 | +117.5% | 0.00% | – |
| Q2 2022 | $1,000 | -97.5% | 200 | -88.2% | 0.00% | – |
| Q1 2022 | $40,000 | -50.6% | 1,696 | -63.0% | 0.00% | – |
| Q4 2021 | $81,000 | -11.0% | 4,583 | +41.5% | 0.00% | – |
| Q3 2021 | $91,000 | +468.8% | 3,240 | +113.4% | 0.00% | – |
| Q2 2021 | $16,000 | -20.0% | 1,518 | -10.0% | 0.00% | – |
| Q1 2021 | $20,000 | +150.0% | 1,686 | +142.2% | 0.00% | – |
| Q4 2020 | $8,000 | – | 696 | +2926.1% | 0.00% | – |
| Q3 2020 | $0 | – | 23 | +9.5% | 0.00% | – |
| Q2 2020 | $0 | -100.0% | 21 | -60.4% | 0.00% | – |
| Q1 2020 | $1,000 | -85.7% | 53 | -88.2% | 0.00% | – |
| Q4 2019 | $7,000 | +250.0% | 448 | +56.6% | 0.00% | – |
| Q3 2019 | $2,000 | – | 286 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 3,962,202 | $19,415,000 | 7.94% |
| TRV GP IV, LLC | 2,343,154 | $11,481,000 | 7.55% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 949 | $193,741,000 | 2.02% |
| Logos Global Management LP | 1,950,000 | $9,555,000 | 1.75% |
| COWEN AND COMPANY, LLC | 2,385,885 | $11,691,000 | 1.13% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 3,355,624 | $16,443,000 | 0.62% |
| ACUTA CAPITAL PARTNERS, LLC | 200,000 | $980,000 | 0.55% |
| RTW INVESTMENTS, LP | 3,961,194 | $19,410,000 | 0.50% |
| Parkman Healthcare Partners LLC | 262,689 | $1,287,000 | 0.47% |
| Deep Track Capital, LP | 1,000,000 | $4,900,000 | 0.32% |